Intended for healthcare professionals

Letters

Some patients stop treatment when variables improve

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7505.1449-c (Published 16 June 2005) Cite this as: BMJ 2005;330:1449
  1. K Kain, senior lecturer in community diabetes (k.kain@leeds.ac.uk),
  2. A J Catto, senior lecturer
  1. Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT
  2. Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT

    EDITOR—Lawton et al describe perceptions of oral hypoglycaemic agents among people of Pakistani and Indian origin.1 We have observed another phenomenon quite often among patients. When treatment is started in asymptomatic patients with high blood pressure or high plasma glucose picked up on screening the general population, …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription